CompletedNot Applicable

Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation

100 participantsStarted 2012-07-01

Plain-language summary

The aim of our study was to investigate, whether enhancement of left atrial cryoablation by ablation of the autonomic nervous system of left atrium leads to influencing the outcomes of surgical treatment of atrial fibrillation in patients with structural heart disease undergoing open-heart surgery.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Indication for open-heart surgery (mitral valve disease and/or tricuspidal valve disease and/or aortic valve disease and/or coronary artery disease and/or other) * Concomitant paroxysmal, persistent, long standing persistent atrial fibrillation * Signing of the informed consent Exclusion Criteria: * Age below 40 and over 80 years of age * Left ventricular ejection fraction below 25% * Left atrium diameter over 60mm * Permanent atrial fibrillation * Polymorbidity (Euroscore II over 10) * Emergency surgery * Renal insufficiency (creatinine over 200 umol/l)

What they're measuring

Sinus Rhythm

Timeframe: 30 months

Trial details

NCT IDNCT03239262

SponsorUniversity Hospital Ostrava

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-01-31

View on ClinicalTrials.gov More Mitral Valve Disease trials